Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Asset Writedowns and Impairment (2018 - 2022)

Historic Asset Writedowns and Impairment for Anterix (ATEX) over the last 5 years, with Q1 2022 value amounting to $127000.0.

  • Anterix's Asset Writedowns and Impairment rose 18222.22% to $127000.0 in Q1 2022 from the same period last year, while for Dec 2021 it was -$82000.0, marking a year-over-year decrease of 25471.7%. This contributed to the annual value of $85000.0 for FY2021, which is 8478.26% up from last year.
  • Anterix's Asset Writedowns and Impairment amounted to $127000.0 in Q1 2022, which was up 18222.22% from -$254000.0 recorded in Q4 2021.
  • In the past 5 years, Anterix's Asset Writedowns and Impairment registered a high of $534000.0 during Q2 2018, and its lowest value of -$254000.0 during Q4 2021.
  • For the 5-year period, Anterix's Asset Writedowns and Impairment averaged around $70307.7, with its median value being $33000.0 (2019).
  • Examining YoY changes over the last 5 years, Anterix's Asset Writedowns and Impairment showed a top increase of 24615.38% in 2021 and a maximum decrease of 240909.09% in 2021.
  • Quarter analysis of 5 years shows Anterix's Asset Writedowns and Impairment stood at $200000.0 in 2018, then plummeted by 83.5% to $33000.0 in 2019, then plummeted by 66.67% to $11000.0 in 2020, then plummeted by 2409.09% to -$254000.0 in 2021, then skyrocketed by 150.0% to $127000.0 in 2022.
  • Its Asset Writedowns and Impairment stands at $127000.0 for Q1 2022, versus -$254000.0 for Q4 2021 and $112000.0 for Q3 2021.